LLY

Eli Lilly and
LLY

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$709.79B
EV
$744.80B
Shares Outstanding
897.74M
Beta
0.40

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$952.05
P/E 2025E
36.21x
P/Revenue 2025E
11.87x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Eli Lilly and Company

gainify
LLY

Eli Lilly and Company

LLY

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humuli...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Ricks, David

Employees

47,000

IPO Date

1972-06-01

Headquarters

Lilly Corporate Center, Indianapolis, Indiana, 46285, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.